6-K - SPHL - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026

Commission File Number: 001-42305

SpringviewHoldings Ltd

(Translation of registrant’s name into English)

203 Henderson Road

#06-01

Henderson Industrial Park

Singapore 159546

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS REPORT

Hung Yu Wu Resigns as Independent Director of the Company

Effective March 13, 2026, Mr. Hung Yu Wu resigned from his position as an independent director of Springview Holdings Ltd (the “Company”), including as a member and chairperson of the Company’s audit committee and as a member of the Company’s compensation committee and nominating and corporate governance committee. Mr. Wu’s resignation was not due to any disagreements with the Company regarding its operations, policies, or practices.

Chin Leng Tan Appointed as Independent Director and Chairpersonof the Audit Committee of the Company

Effective March 13, 2026, following Mr. Wu’s resignation, the Company appointed Mr. Chin Leng Tan as an independent director of the Company and as a member and chairperson of the Company’s audit committee and as a member of the Company’s compensation committee and nominating and corporate governance committee.

Mr. Tan will receive a monthly compensation of US$2,000 payable on a quarterly basis, and will be reimbursed for reasonable expenses incurred in connection with the performance of his duties.

The biographical information of Mr. Chin Leng Tan is set forth below:

Mr. Chin Leng Tan has served as Business Development Director of CIIHE (UK) since June 2024. From May 2019 to May 2024, Mr. Tan served as Asia Country Head of OTHM Qualifications (UK), where he was responsible for establishing a strong and sustainable presence for OTHM qualifications across Asia by developing the market, building trusted delivery networks, and securing the necessary regulatory approvals. From February 2015, Mr. Tan served as Chief Executive Officer of City Metropolitan College, where he was responsible for setting up the college, obtaining the license to operate and conduct diploma and advanced diploma courses in Singapore, and turning the college from a negative to positive P&L. From February 2013, Mr. Tan served as Special Project Director of Coleman College. From January 2012, Mr. Tan served as Managing Director of United World School of Business. From December 2006 to May 2009, Mr. Tan served as Supply Chain Manager of Thales Aerospace Asia Limited. Mr. Tan received a Doctorate of Business Administration degree from International University of Georgia, a Master of Business Administration degree in General Management from Central Queensland University, and a Bachelor of Business degree in Transport and Logistics Management from Royal Melbourne Institute of Technology University.

EXHIBIT INDEX

Exhibit No.	Description
10.1	Director Offer Letter between the Company and Mr. Chin Leng Tan

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Springview Holdings Ltd
Date: March 17, 2026	By:	/s/ Zhuo Wang
	Name:	Zhuo Wang
	Title:	Chief Executive Officer

Exhibit 10.1

INDEPENDENT DIRECTOR OFFER LETTER

March 13, 2026

Re: Independent Director Offer Letter – Chin Leng Tan

Dear Mr. Tan

SPRINGVIEW HOLDINGS LTD, a Cayman Islands limited liability company (the “Company” or “we”), is pleased to offer you a position as an Independent Director of the Company. We believe your background and experience will be a significant asset to the Company and we look forward to your participation as an Independent Director in the Company. Should you choose to accept this position as an Independent Director, this letter agreement (the “Agreement”) shall constitute an agreement between you and the Company and contains all the terms and conditions relating to the services you agree to provide to the Company. Your appointment shall also be subject to the approval of Company’s Board of Directors and/or Nomination and Compensation Committees.

1.	Term. Your appointment shall begin on the date of this Agreement (the “EffectiveDate”). Your term shall continue subject to the provisions in Section 9 below or until your successor is duly elected and qualified.<br>The position shall be up for re-election at the next following annual meeting of shareholders.
2.	Services. You shall render customary services as an Independent Director and such other<br>duties as are reasonably contemplated by you holding office as an independent director of the Company or which may reasonably be assigned<br>to you by the Board from time to time, including being member of the committee(s) of the Board (hereinafter, your “Duties”).<br>During the term of this Agreement, you may attend and participate at each meeting regarding the business and operation issues of the Company<br>as regularly or specially called, via teleconference, video conference or in person. You shall consult with the members of the Board and<br>committee (if any) regularly and as necessary via telephone, electronic mail or other forms of correspondence.
---	---
3.	Services for Others. You shall be free to represent or perform services for other persons<br>during the term of this Agreement.
---	---
4.	Compensation. As compensation for your services to the Company, you will receive a monthly<br>compensation of US$2,000 payable on a quarterly basis commencing from the Effective Date. You shall be reimbursed for reasonable expenses<br>incurred by you in connection with the performance of your Duties (including travel expenses for in-person meetings).
---	---
5.	D&O Insurance Policy. During the term under this Agreement, the Company shall include<br>you as an insured under its officers and directors’ insurance policy, if available.
---	---
6.	No Assignment. Because of the personal nature of the services to be rendered by you, this<br>Agreement may not be assigned by you without the prior written consent of the Company.
---	---
7.	Confidential Information; Non-Disclosure. In consideration of your access to certain Confidential<br>Information (as defined below) of the Company, in connection with your business relationship with the Company, you hereby represent and<br>agree as follows:
---	---
a)	Definition. For purposes of this Agreement<br>the term “Confidential Information” means: (i) any information which the Company possesses that has been created, discovered<br>or developed by or for the Company, and which has or could have commercial value or utility in the business in which the Company is engaged;<br>(ii) any information which is related to the business of the Company and is generally not known by non-Company personnel; and (iii) Confidential<br>Information includes, without limitation, trade secrets and any information concerning products, processes, formulas, designs, inventions<br>(whether or not patentable or registrable under copyright or similar laws, and whether or not reduced to practice), discoveries, concepts,<br>ideas, improvements, techniques, methods, research, development and test results, specifications, data, know-how, software, formats,<br>marketing plans, and analyses, business plans and analyses, strategies, forecasts, customer and supplier identities, characteristics<br>and agreements.
---	---
b)	Exclusions. Notwithstanding the foregoing,<br>the term Confidential Information shall not include: (i) any information which becomes generally available or is readily available to<br>the public other than as a result of a breach of the confidentiality portions of this Agreement, or any other agreement requiring confidentiality<br>between the Company and you; (ii) information received from a third party in rightful possession of such information who is not restricted<br>from disclosing such information; (iii) information known by you prior to receipt of such information from the Company, which prior knowledge<br>can be documented and (iv) information you are required to disclose pursuant to any applicable law, regulation, judicial or administrative<br>order or decree, or request by other regulatory organization having authority pursuant to the law; provided, however, that you shall<br>first have given prior written notice to the Company and made a reasonable effort to obtain a protective order requiring that the Confidential<br>Information not be disclosed.
---	---
c)	Documents. You agree that, without the express<br>written consent of the Company, you will not remove from the Company’s premises, any notes, formulas, programs, data, records,<br>machines or any other documents or items which in any manner contain or constitute Confidential Information, nor will you make reproductions<br>or copies of same. You shall promptly return any such documents or items, along with any reproductions or copies to the Company upon<br>the Company’s demand, upon termination of this Agreement, or upon your termination or Resignation (as defined in Section 9 herein).
---	---
d)	Confidentiality. You agree that you will hold<br>in trust and confidence all Confidential Information and will not disclose to others, directly or indirectly, any Confidential Information<br>or anything relating to such information without the prior written consent of the Company, except as may be necessary in the course of<br>your business relationship with the Company. You further agree that you will not use any Confidential Information without the prior written<br>consent of the Company, except as may be necessary in the course of your business relationship with the Company, and that the provisions<br>of this paragraph (d) shall survive termination of this Agreement. Notwithstanding the foregoing, you may disclose Confidential Information<br>to your legal counsel and accounting advisors who have a need to know such information for accounting or tax purposes and who agree to<br>be bound by the provisions of this paragraph (d).
---	---
e)	Ownership. You agree that the Company shall<br>own all right, title and interest (including patent rights, copyrights, trade secret rights, mask work rights, trademark rights, and<br>all other intellectual and industrial property rights of any sort throughout the world) relating to any and all inventions (whether or<br>not patentable), works of authorship, mask works, designations, designs, know-how, ideas and information made or conceived or reduced<br>to practice, in whole or in part, by you during the term of this Agreement and that arise out of your Duties (collectively, “Inventions”)<br>and you will promptly disclose and provide all Inventions to the Company. You agree to assist the Company, at its expense, to further<br>evidence, record and perfect such assignments, and to perfect, obtain, maintain, enforce, and defend any rights assigned.
---	---
8.	Non-Solicitation. During the term of your appointment,<br>you shall not solicit for employment any employee of the Company with whom you have had contact due to your appointment.
---	---

9.	Termination and Resignation. Your services<br>as an Independent Director may be terminated for any or no reason by the determination of the Board (including any failure to elect you<br>for an ensuing term at any annual meeting of the Board).You may also terminate your services as an Independent Director for any or no<br>reason by delivering your written notice of resignation to the Company (“Resignation”), and such Resignation shall be effective<br>upon the time specified therein or, if no time is specified, upon receipt of the notice of resignation by the Company. Upon the effective<br>date of the termination or Resignation, your right to compensation hereunder will terminate subject to the Company’s obligations<br>to pay you any compensation that you have already earned as of the effective date of such termination or Resignation.
10.	Governing Law; Arbitration. All questions with<br>respect to the construction and/or enforcement of this Agreement, and the rights and obligations of the parties hereunder, shall be determined<br>in accordance with the law of the State of New York. All disputes with respect to this Agreement, including the existence, validity,<br>interpretation, performance, breach or termination thereof or any dispute regarding non-contractual obligations arising out of or relating<br>to it shall be referred to and finally resolved by arbitration administered by the American Arbitration Association at its New York office<br>in force when the Notice of Arbitration is submitted. The law of this arbitration clause shall be New York law. The seat of arbitration<br>shall be in New York. The number of arbitrators shall be one. The arbitration proceedings shall be conducted in English.
---	---
11.	Entire Agreement; Amendment; Waiver; Counterparts.<br>This Agreement expresses the entire understanding with respect to the subject matter hereof and supersedes and terminates any prior oral<br>or written agreements with respect to the subject matter hereof. Any term of this Agreement may be amended and observance of any term<br>of this Agreement may be waived only with the written consent of the parties hereto. Waiver of any term or condition of this Agreement<br>by any party shall not be construed as a waiver of any subsequent breach or failure of the same term or condition or waiver of any other<br>term or condition of this Agreement. The failure of any party at any time to require performance by any other party of any provision<br>of this Agreement shall not affect the right of any such party to require future performance of such provision or any other provision<br>of this Agreement. This Agreement may be executed in separate counterparts each of which will be an original and all of which taken together<br>will constitute one and the same agreement, and may be executed using facsimiles of signatures, and a facsimile of a signature shall<br>be deemed to be the same, and equally enforceable, as an original of such signature.
---	---
12.	Indemnification. The Company shall, to the<br>maximum extent provided under applicable law, indemnify and hold you harmless from and against any expenses, including reasonable attorney’s<br>fees, judgments, fines, settlements and other legally permissible amounts (“Losses”), incurred in connection with any proceeding<br>arising out of, or related to, your performance of your Duties, other than any such Losses incurred as a result of your gross negligence<br>or willful misconduct. The Company shall advance to you any expenses, including reasonable attorneys’ fees and costs of settlement,<br>incurred in defending any such proceeding to the maximum extent permitted by applicable law. Such costs and expenses incurred by you<br>in defense of any such proceeding shall be paid by the Company in advance of the final disposition of such proceeding promptly upon receipt<br>by the Company of (a) written request for payment; (b) appropriate documentation evidencing the incurrence, amount and nature of the<br>costs and expenses for which payment is being sought; and (c) an undertaking adequate under applicable law made by or on your behalf<br>to repay the amounts so advanced if it shall ultimately be determined pursuant to any non-appealable judgment or settlement that you<br>are not entitled to be indemnified by the Company.
---	---
13.	Acknowledgement. You accept this Agreement<br>subject to all the terms and provisions of this Agreement. You agree to accept as binding, conclusive, and final all decisions or interpretations<br>of the Board of Directors of the Company of any questions arising under this Agreement.
---	---

The Agreement has been executed and delivered by the undersigned and is made effective as of the date set first set forth above.

Sincerely,
SPRINGVIEW HOLDINGS LTD
By:	/s/ Zhuo Wang
	Zhuo Wang
	Chairman & Chief Executive Officer
AGREED AND ACCEPTED:
---
/s/ Chin Leng Tan
Name: Chin Leng Tan